O106 A CHEMORADIOTHERAPY TREATMENT RESPONSE MRNA SIGNATURE AS PREDICTOR FOR ESOPHAGEAL ADENOCARCINOMA TREATED ACCORDING TO THE CROSS REGIMEN. (23rd November 2019) - Hoefnagel, S J M; Koster, J; Koemans, W J; van Dieren, J M; van Sandick, J W; Kodach, L L; Calpe, S; Meijer, S L; del Sancho-Serra, C M; Khan, H N; Van Laarhoven, H W M; Van Berge Henegouwen, M I; et al.